Citigroup analyst Andrew Kaplowitz maintains A.O. Smith (NYSE:AOS) with a Neutral and raises the price target from $63 to $69.
Good News For Toddlers With Peanut Allergy: DBVT Data Shows Promising Results for Peanut Allergy Patch
DBV Technologies (NASDAQ: DBVT) (OTC: